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Abstract In January 2014, an international meeting
sponsored by the International Life Sciences Institute/
Health and Environmental Sciences Institute and the
Canadian Food Inspection Agency titled ‘‘Genetic
Basis of Unintended Effects in Modified Plants’’ was
held in Ottawa, Canada, bringing together over 75
scientists from academia, government, and the agro-
biotech industry. The objectives of the meeting were
to explore current knowledge and identify areas re-
quiring further study on unintended effects in plants
and to discuss how this information can inform and
improve genetically modified (GM) crop risk assess-
ments. The meeting featured presentations on the
molecular basis of plant genome variability in general,
unintended changes at the molecular and phenotypic
levels, and the development and use of hypothesis-
driven evaluations of unintended effects in assessing
conventional and GM crops. The development and
role of emerging ‘‘omics’’ technologies in the assess-
ment of unintended effects was also discussed. Several
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themes recurred in a number of talks; for example, a
common observation was that no system for genetic
modification, including conventional methods of plant
breeding, is without unintended effects. Another
common observation was that ‘‘unintended’’ does not
necessarily mean ‘‘harmful’’. This paper summarizes
key points from the information presented at the
meeting to provide readers with current viewpoints on
these topics.
Keywords Unintended effects  GM crop plants 
Environmental risk assessment  Allergenicity 
Toxicity
Introduction
As genetically modified (GM) crops worthy of com-
mercialization became available, procedures were in-
stituted to ensure that these plants were as safe for
food, feed, and environmental release as their con-
ventional (non-GM) counterparts. These procedures
addressed two broad categories of changes that could
be considered in a GM crop safety assessment: in-
tended and unintended. The intended change in a new
GM product is the desired phenotype brought about by
the introduced transgene. Because many transgenes
express a known and characterized protein, procedures
can be developed that directly assess the protein for
toxicity and allergenicity and measure levels of
metabolites that may be associated with the protein’s
function. Unintended changes, on the other hand,
could materialize as a consequence of gene insertion,
from random mutations that take place during the
transformation and tissue culture process, or from
pleiotropic effects of the introduced protein, and there
is no single direct test for them.
In January 2014, an international meeting spon-
sored by the International Life Sciences Institute/
Health and Environmental Sciences Institute and the
Canadian Food Inspection Agency titled ‘‘Genetic
Basis of Unintended Effects in Modified Plants’’ was
held in Ottawa, Canada, bringing together over 75
scientists from academia, government, and the agro-
biotech industry. The objectives of the meeting were
to explore current knowledge and identify areas re-
quiring further study on unintended effects in plants
and to discuss how this information can inform and
improve GM crop risk assessments.
The potential for an unintended effect to present a food
or feed hazard is currently assessed through composi-
tional analyses and agronomic studies to compare the GM
crop with a genetically similar conventional counterpart.
Some regulatory authorities, such as those in the Euro-
pean Union (EC 2013), may also require animal feeding
tests. Some aspects of testing for unintended effects seem
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to be generally accepted, such as the use of related con-
ventional comparators. Nevertheless, many questions are
still being discussed, for example, whether it is sufficient
to limit testing for unintended effects to those subject to
testable hypotheses, or whether (and when) the precau-
tionary principle requires a broader look for genomic
changes via profiling methods. As noted during the
opening presentation and by several other speakers,
‘‘unintended’’ is not synonymous with ‘‘harmful’’ (e.g.,
NRC 2004).
This manuscript summarizes four broad areas dis-
cussed at the meeting: the molecular changes associ-
ated with plant genetic variability, the types of
unintended genomic changes in GM plants, the use of
hypothesis-driven evaluations of unintended effects,
and the use of emerging technologies in the assess-
ment of unintended effects. This paper is based on the
meeting presentations, with new and updated infor-
mation added where appropriate. For each section, the
primary contributors are noted, but comments and
edits from other authors have been included. The au-
thors’ individual papers in their entirety are available
as Online Resource 1. Presentations and other infor-
mation from the meeting can be found at http://www.
hesiglobal.org/i4a/pages/index.cfm?pageID=3654.
Molecular basis of plant genetic variability1
High-throughput sequencing and other genomic
technologies have made it possible to evaluate the
nature and extent of naturally occurring genomic
changes in plants. These were extensively reviewed by
Weber et al. (2012), who noted the following:
• Single-nucleotide changes are common, with a
background rate of seven new mutations per
billion bp of DNA, or roughly seven new muta-
tions for every soybean (Glycine max) plant in
every field (Ossowski et al. 2010).
• Insertions from transposons can be very common as
well, with rates as high as 50 novel insertions per plant
per generation reported in a variety of rice (Oryza
sativa; Naito et al. 2006). Transposon insertions are
also very common in soybean (Tian et al. 2012).
• Plants create novel genes through transposon
capture, whereby pieces of different genes are
assembled in novel combinations (reviewed in
Weber et al. 2012).
• There are genes that are present in different
numbers or absent altogether in different indi-
viduals within a crop (e.g., Lai et al. 2010; Lam
et al. 2010; Potato Genome Consortium 2011;
McHale et al. 2012).
• Horizontal gene transfer is not uncommon, with
pararetroviral (double-stranded DNA virus) se-
quences being particularly abundant in the gen-
omes of crop plants (e.g., Liu et al. 2012; Staginnus
et al. 2007).
The effects of naturally occurring insertions are of
particular interest because plant genetic engineering is
typically mediated by the insertion of a modified
T-DNA sequence from Agrobacterium tumefaciens or
other vector DNA sequences into the genome. This
insertion may potentially disrupt the function of native
genes and can create rearrangements at the site of in-
sertion. Indeed, roughly half of T-DNA insertions
exhibit less than 8 bp of ‘‘filler’’ DNA at the junction
site, while the other half contain larger additions,
generally between 8 and 100 bp (Forsbach et al.
2003). Short insertions, comparable to those seen at
T-DNA junctions, have been observed in induced
double-strand break experiments (Lloyd et al. 2012;
Vu et al. 2014). Such insertion variation is common,
even in closely related rice varieties, and reflects the
fact that errors in double-strand break repair are fre-
quent in natural and breeding populations (Vaughn
and Bennetzen 2014). Thus, the ‘‘filler’’ DNA ob-
served in T-DNA insertions has a clear counterpart in
naturally occurring DNA insertions.
In summary, the view that only transgenes result in
insertions, and that these have a unique ability to
disrupt gene expression (e.g., Fagan et al. 2014) is not
supported by the available data. Instead, plant gen-
omes are very dynamic and plastic, as predicted by
Barbara McClintock (1984) in her Nobel address, and
undergo frequent insertions and other rearrangements.
Molecular basis of unintended effects in GM plants
In addition to the potential for insertional effects of
transgenes, other mechanisms such as somaclonal
variation and pleiotropy can contribute to unintended
effects.
1 Section based on presentations from Wayne Parrott and Justin
Vaughn.
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Somaclonal variation2
Semi-differentiated plant tissues cultured in vitro are
critical for most plant transformation methods. In vitro
culture induces genetic and epigenetic changes, ter-
med somaclonal variation (SCV; Larkin and Scow-
croft 1981), that are another possible source of
unintended variation. Although SCV is potentially
useful as a source of novel mutations, it is contrary to
the objective of making limited, predictable changes
as a result of transgene introduction. For example,
significant and negative changes have been noted in
the agronomic performance and malting quality of
tissue-culture-derived barley. Yield losses of 15–84 %
have been observed in non-transgenic derivatives of
transgenic plants, i.e., non-transgenic segregants
derived from heterozygous transgenic plants (Bregit-
zer et al. 1998). Although certain adjustments to the
in vitro environment can reduce the severity of SCV,
the most effective way to eliminate it in barley has
been to backcross transgenic plants to plants without
any SCV (such as the wild-type parent used in
making the original transgenic plant), with selection
at each generation based only on the presence of the
transgene. For example, a single backcross to barley
cultivar Conlon recovered the majority of yield loss
caused by SCV in a group of transgenic Conlon-
derived lines. On average, the yield loss in the
primary transgenic lines was 31 %, compared with
6 % in the backcross-derived lines (Bregitzer and
Dahleen 2008).
Pleiotropic effects of transgenes3
Some unintended effects might be caused by
pleiotropy, the effect of a single gene (whether a native
gene or a transgene) on multiple traits (Fagan et al.
2014). When both positive and negative effects are
caused by the same gene, it is referred to as an-
tagonistic pleiotropy. An example of antagonistic
pleiotropy is the wheat (Triticum aestivum) gene Lr34,
which encodes an ABC transporter, a molecule in-
volved in the transport of metabolites across mem-
branes (Krattinger et al. 2009). Lr34 provides durable
resistance to a number of wheat diseases; however, it
also causes premature senescence of the flag leaf (leaf
tip necrosis) that can reduce potential yield in the
absence of disease. If the wheat Lr34 gene is moved
into barley (Hordeum vulgare), the negative effect
becomes stronger and the plants exhibit stunted
growth and sterility (Risk et al. 2013). One possible
explanation is that wheat has regulatory mechanisms
that control the expression of the gene in a manner that
minimizes its negative effects; on the other hand, the
barley lines tested were primary transgenic lines and
had not undergone selection against SCV (described in
the previous section). The amount of leaf tip necrosis
varies among wheat genotypes, but plant breeders
have selected lines that maximize the benefit while
reducing the negative effect of the gene. The same
may be possible in barley if the detrimental effects
seen are due to somaclonal variation rather than to
pleiotropy.
Prediction of whether pleiotropy (and therefore the
possibility of unintended effects) is likely to occur as
the result of a transgene depends on knowledge of the
biochemical mechanism of the encoded protein. Genes
affecting basic cellular functions that are needed by
many traits (such as ABC transporters) are more likely
to be pleiotropic. Similarly, genes in which alternative
splicing occurs in the pre-mRNA or that encode a
protein affecting multiple pathways (e.g., transcription
factors or other regulatory proteins or molecules)
could potentially be pleiotropic.
A gene’s origin may also be an indicator of whether
pleiotropy is likely to occur, but this is harder to pre-
dict. There could be more pleiotropy if the gene ori-
ginates from another species due to lack of regulatory
controls (e.g., expression of wheat Lr34 in barley) or
less pleiotropy due to lack of a pathway or function in
the recipient species compared with the donor (origi-
nal) species. An example of this is the lack of antho-
cyanin production in transgenic tomato (Lycopersicon
esculentum) fruit after the introduction of genes
regulating flavonol and anthocyanin production from
maize (Zea mays) (Bovy et al. 2002). The tomato
plants had increases in some flavonols but no antho-
cyanin production because tomato lacks sufficient
expression of another gene required for anthocyanin
production. Variation in regulatory mechanisms is not
only observed at the species level—different geno-
types of the same species can have variation in
regulatory mechanisms (e.g., Schiessl et al. 2014),
which is one reason there is so much phenotypic and
2 Section based on presentation by Phil Bregitzer.
3 Section based on presentation by Mark Jordan.
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phenologic diversity in crop species. Without this type
of diversity, selection during plant breeding would be
less effective.
Similarity between unintended effects
in conventional plant breeding and biotechnology4
Plant breeders have successfully improved crop yields
despite having little or no information on the genes and
gene networks that impact yield. In the case of maize, it
is clear that improvements in grain yield have been
associated with significant changes in many other traits
(Tollenaar and Lee 2010). Whereas in conventional
plant breeding, the exact functions of the combined
genes are mainly unknown, biotechnology enables the
introduction of specific genes with expected effects on
endogenous pathways and phenotypes.
Although crop plants derived from conventional
plant breeding and GM differ in the level of molecular
data required for commercialization, both conven-
tional breeding products and GM products undergo a
similar process of selection for intended characteris-
tics and elimination of undesirable phenotypes (Pri-
valle et al. 2012). While it is clear that unintended
effects occur in any type of breeding program, in-
cluding conventional crossing (Cellini et al. 2004; Kok
et al. 2008; Schnell et al. 2015), the discussion on the
potential for unintended events tends to be focused on
GM organisms.
This similarity between the changes caused by
biotechnology and conventional plant breeding is re-
flected in the approach to regulation used in Canada.
The Canadian regulatory scope covers plants devel-
oped to possess characteristics sufficiently different
from those of the same or similar species, regardless of
the method used. As a consequence of the product-
based regulatory approach, in Canada the regulated
plant is referred to as a plant with a novel trait (PNT).
PNTs include GM crops as well as some produced by
more conventional breeding techniques. The approach
is designed to take advantage of the knowledge, ex-
pertise, and regulatory framework that are already
present in regulatory departments and agencies but
applied to conventional products. It is also an ac-
knowledgment that the Canadian Government policy
considers that PNT crops should be considered as an
extension of conventional breeding techniques and
that the focus of assessment should be on the novel
trait rather than on how the trait was obtained.
The GM product development process5
The extensive vetting involved in the generation and
selection of one or a few ‘‘elite’’ (i.e., top-performing)
events minimizes the likelihood of unsafe unintended
effects associated with the GM crop products that are
taken to commercialization. Many ideas, traits, and
events are evaluated to identify an event for which it is
worth seeking approval (e.g., Phillips McDougall
2011; Privalle et al. 2012). As noted earlier, this is not
unlike the approach taken by breeders seeking to de-
velop a new and improved variety.
For GM crops, as for those derived from conven-
tional breeding, the most important selection criterion
is efficacy/performance (i.e., does the trait impart the
desired phenotype, meeting product specifications). In
the case of GM crops, the next most important criteria
applied in identifying the lead event are those related to
the molecular characteristics of the event. The inserted
DNA ideally should be present at a single locus and as a
single copy. There should be no vector backbone pre-
sent in the event and the insertion should not have
disrupted an endogenous gene or created a chimeric
novel fusion protein. There should be minimal locus
rearrangement and the integrity of the gene cassette
should have been preserved. Importantly, while none
of these parameters have been demonstrated to impact
the safety of the crop, the consideration of these pa-
rameters is based on hypothetical, minimal-probability
possibilities. Since most GM products require multiple
approvals, the requirements from the strictest juris-
dictions dominate the event selection criteria.
Once the elite event is identified, an extensive safety
assessment is conducted that includes studies on the
safety of the newly expressed protein, molecular
characterization of the insert, impact of the insert on
plant performance and composition, environmental
impact, and wholesomeness of the crop (SCBD 2000;
Codex 2003). The assessment includes phenotypic and
agronomic comparison between the new plant variety
and a genetically similar comparator that is already on
the market and considered as safe. GM foods are among
4 Section based on presentations by Elena Rice, Esther Kok,
and Phil Macdonald. 5 Section based on presentation by Laura Privalle.
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the most highly studied foods consumed, and the regis-
tration dossiers are scrutinized by regulatory agencies
around the world. To date, approval has not been withheld
for any event based on an unintended effect.
Hypothesis-driven evaluation of unintended effects
Approaches to risk assessment6
Risk is a combination of the seriousness and likelihood
of a harmful effect following a course of action. Risk
assessment characterizes the amount of risk associated
with an activity. It contributes to making decisions
about whether to undertake an activity, such as the
import, field testing, or cultivation of a specific GM
crop. Some authors have raised concern (e.g., Craig
et al. 2008) that the amount of data required for risk
assessments of GM crops is increasing and becoming
detrimental to decision-making in many countries.
Two possible approaches to risk assessment have
been described. In the ‘‘bucket’’ approach (Raybould
2011), data on the properties of the GM crop are col-
lected in an untargeted manner, often termed profiling.
Profiling could comprise measurements of the crop’s
gross phenotype, composition of key tissues, tran-
scriptome, proteome, metabolome, and so on. By
comparing these profiles with those of a suitable
conventional crop, the risk assessor is supposed to be
able to identify changes, which in turn indicate that
there may be changes in the GM crop that are poten-
tially harmful (see ‘‘Omics technologies’’ below).
There are several limitations to this approach. First,
what to regard as harmful is defined by policy; it is not
discovered in data (Sarevitz 2004; Sanvido et al.
2012). Second, even if harm is defined, profiling will
collect data that do not predict the seriousness or
probability of harm following use of the GM crop.
These data are thus irrelevant for risk assessment and
may impair decision-making because they distract
from data that are relevant. Furthermore, it is difficult
to interpret the effect of an altered metabolite in the
absence of a hypothesis.
The second approach regards risk assessment as a
hypothesis-testing exercise. The risk assessor identi-
fies those effects that would be regarded as harmful if
they were to occur, based on relevant legislation or
regulations (Evans et al. 2006), and builds scenarios
comprising a series of events leading from the pro-
posed use of the particular GM crop to the identified
harmful effects. These scenarios, or ‘‘pathways to
harm’’, allow the risk assessor to devise testable hy-
potheses about the likelihood, frequency, or magni-
tude of the events in the pathway. Data are collected to
test these hypotheses and thereby characterize risk
(Raybould 2011).
A concern raised about the latter approach is that it
represents a biased approach to assessment. Effective
risk assessment does involve bias in that representative
protection goals must be selected from among all the
possible effects of using a GM crop. Limited resources
are then targeted to test hypotheses about the prob-
ability and consequences of those effects. These will be
strong tests of clear hypotheses, which, if corroborated,
provide high confidence in conclusions of low risk.
Problem formulation in environmental risk
assessment7
Environmental risk assessment (ERA) for GM crops
deals almost exclusively with the phenotype and
considers all plant traits that may have been altered by
the transformation, whether intended or unintended.
Of particular interest are any unintended changes in
traits that may make the GM plant more persistent or
invasive (‘‘weedy’’) in either agricultural or natural
environments. These include changes in the properties
of the seeds (such as developmental rates, number,
release from the plant [shattering], dormancy, and
germination rates) that are important in the ‘‘regen-
eration niche’’ of the plant’s establishment and spread,
and in those traits that affect the plant’s competitive-
ness (such as seedling vigor, plant height, growth
rates, and resistance to pests and disease).
The first stage in problem formulation in an ERA is
to identify a set of environmental protection goals
derived from local, national, or international policy.
These may be broadly stated (e.g., the Cartagena
Protocol) or more specific laws, statutes, or even
guidelines, but collectively they enable a risk assessor
to identify those aspects of the environment that must
be protected. These can sometimes be formally
6 Section based on presentation by Alan Raybould. 7 Section based on presentation by Alan Gray.
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defined in terms of assessment endpoints (e.g., ‘‘insect
pollinator abundance’’), which are whatever will be
measured to ascertain whether protection has been
achieved as intended (Paes de Andrade et al. 2014).
The second stage of problem formulation is to seek a
link between the cultivation of the GM crop and the
assessment endpoint that may result in harm (i.e., the
pathway to harm). For example, insect pollinators are
likely to be harmed if the plant presents a hazard (e.g., an
insecticidal protein that negatively affects the insect) to
which the insect may be exposed. Steps along the path-
way to harm can be recast as risk hypotheses that can be
validated or rejected from existing data, or by designing
new experiments or trials where appropriate. For ex-
ample, validation of the hypothesis ‘‘the insect is not
harmed by the protein’’ or ‘‘the protein is not expressed
in pollen’’ allows a confident risk assessment without
further experimentation. Wolt et al. (2010) describe the
process in detail and Raybould (2011) and earlier papers
referred to therein give specific examples of formulating
and testing risk hypotheses. Gray (2012) and Tepfer et al.
(2013) give practical examples of the use of problem
formulation in ERA for GM crops.
Evaluation of food and feed safety
As mentioned earlier, the approach to food and feed
safety described by the Codex Alimentarius Commis-
sion (Codex 2003) is based on comparison of the GM
crop to a conventional counterpart employing a weight-
of-evidence approach. In this way, the assessment is
focused on identification of potential new hazards or
changes in hazard levels in the GM product.
Focus on plausible outcomes8
For food and feed safety risk assessment of GM crops,
it is necessary to exclude hypothetical, extreme, or
scientifically implausible circumstances. Instead, the
purpose is to (1) identify practical, biologically plau-
sible outcomes based on the extensive data now
available, and (2) to define the nature of the at-risk
group(s) to be addressed (population or individual
health risks), the type of hazard(s) of concern
(toxicological, dietary, immunological), and the risk
time metric (acute, sub-chronic, or chronic).
It is unlikely that systemically toxic proteins that
are unrelated to the parent plant variety or to the
function of the transgene will be produced de novo
in a GM plant (Weber et al. 2012). The reason is
that systemic toxicity of an ingested protein requires
at least three highly specific structural characteris-
tics: (1) resistance to digestion, (2) ligand specificity
for the gut uptake transporters, and (3) ligand/re-
ceptor specificity for site- and species-specific re-
ceptor-mediated toxicity (Hammond et al. 2013). A
change in any one of these three characteristics is an
implausible outcome from either conventional plant
breeding or gene transfer; thus, the probability of
having all three occur in the same plant is vanish-
ingly small. Similarly, the potential for random
genome effects to modify existing non-toxic proteins
to create a toxic protein is also essentially zero
(Weber et al. 2012). This prediction is evidenced by
the current knowledge of conventional corn and
other food crop varieties that have millions of sin-
gle-nucleotide polymorphisms (SNPs) across geno-
types (Tenaillon et al. 2001), but have never resulted
in a novel toxic protein in a food crop (Steiner et al.
2013).
The de novo generation of the machinery necessary
to produce a toxic secondary metabolite is also very
unlikely. Such an event has not been observed in the
extensive range of varieties produced by genetic ma-
nipulation in conventional and GM crop breeding over
the past century. The reactivation of dormant path-
ways (i.e., pathways present in an ancestor of the crop
that are inactive in the modern variety) has also never
been observed and is implausible due to the accumu-
lation of mutations in non-functional DNA, progres-
sively degrading any residual potential functionality
(Steiner et al. 2013).
As in conventional plant breeding, there are natural
variations in the levels of compounds, including those
of toxicological relevance, in crops developed through
modern biotechnology. Examples of plausible
mechanisms include the up (and down) regulation of
pre-existing endogenous plant toxins, increased/de-
creased uptake of heavy metals from the soil or water
(e.g., Cd, As, Se), altered levels of nutrients or
antinutrients associated with population health out-
comes, altered production of pesticide metabolites,
altered levels of toxic substrates (precursors) due to
blocking of an enzyme pathway, and altered release or
availability of endogenous toxins.8 Section based on presentation by Andrew Bartholomaeus.
Transgenic Res (2015) 24:587–603 593
123
Assessment for changes in levels of existing allergens9
According to the European Union perspective on the
assessment of the overall allergenicity of whole GM
plants, in cases where the recipient species of a genetic
modification is a known allergen, (e.g., soybean) the
qualitative and quantitative composition of endoge-
nous allergens in the GM crop and its conventional
counterpart should be compared (Metcalfe et al.
1996). The concentration of endogenous allergens
within a plant species is highly variable, and the
comparative analysis should consider the influence of
the cultivars and of the conditions of cultivation,
harvest, storage, and processing on the expression of
allergens (see ‘‘Examples of natural variation in al-
lergens’’ below). The European Food Safety Authority
(EFSA) guidance and the European Commission (EC)
regulation have recommended including ‘‘key’’ en-
dogenous allergens (i.e., such as those listed in the
OECD consensus documents) in the comparative
compositional analysis of plant materials collected
from controlled field trials. This aims to assess whe-
ther the GM plant is more allergenic than its conven-
tional counterpart (EFSA 2011; EC 2013). As
described by the EC, ‘‘key allergens’’ are well-char-
acterized allergens that are relevant for public health
because of their allergenic potency and abundance.
They are generally well-conserved proteins with im-
portant metabolic and physiological functions in the
plant, such as enzymes, defense proteins, or storage
proteins. Any significant change in key allergen levels
could thus be directly related to the specific allergy
risk and could also indicate the possible occurrence of
other types of unintended effects.
Non-targeted analyses, such as proteomic ap-
proaches using mass spectrometry (e.g., matrix-as-
sisted laser desorption/ionization (MALDI) or
electrospray ionization time-of-flight mass spec-
trometry (ESI-TOF MS) in combination with different
separation methods such as 2-dimensional gel elec-
trophoresis or liquid chromatography), have been
rapidly developed (Goodman et al. 2013) and can help
to identify significant changes in endogenous allergen
expression. They may not require human sera and have
proven to be efficient (alternative) tools for the iden-
tification and quantification of known allergens in
plants. However, such tests may sometimes be con-
sidered as complex and insufficiently standardized and
needing further developments and validation before
they can be routinely used for safety assessment
(Fernandez et al. 2013).
Examples of natural variation in allergens10
Allergies to fruits and vegetables affect up to*4 % of
the population in Europe (Zuidmeer et al. 2008).
Carrot (Daucus carota) and apple (Malus domestica)
are among the most prevalent elicitors of allergic re-
actions to foods in northern and central Europe. In
apple, variation in patient reaction and/or allergen
levels has been observed among cultivars (Bolhaar
et al. 2005), stored vs. unstored fruit (Sancho et al.
2006a, b), and patient geographical areas. Similarly,
the carrot isoallergens (related allergens from the same
species) Dau c 1.01 and Dau c 1.02 were quantified
using ELISA (Foetisch et al. 2011) in two cultivars,
‘Rodelica’ and ‘Nerac’, in a two-year study. Initial
evaluation of the field data suggests a large influence
of the year of cultivation and an apparent difference
between the two cultivars (unpublished data, re-
search project BO¨L 03OE349 granted by the Ger-
man Federal Ministry of Food, Agriculture and
Consumer Protection). Furthermore, some isoaller-
gens might be more relevant than others for clinical
reactivity, and the level of allergens can increase or
decrease depending on genetic and environmental
factors. Studies on the allergenicity of apple and
carrot have focused on non-transgenic cultivars;
however, they can be considered model foods to
study the influence of genetic and environmental
factors on the composition of panallergenic struc-
tures (functionally related allergenic molecules
found in different species) and the isoallergen dis-
tribution in fruits and vegetables. Understanding the
biochemical pathways of allergen synthesis and the
range of natural variability may support hypothesis-
driven studies on unintended effects in GM plants
intended for human consumption.
9 Section based on presentation by Jean-Michel Wal. 10 Section based on presentation by Thomas Holzhauser.
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Environmental risk assessment of GM crop plants
Example of hypothesis-driven testing: drought-
tolerant maize11
The evaluation of Monsanto’s recently introduced
DroughtGard maize hybrids (event MON 87460)
was used as a case study to illustrate how hypothesis-
driven testing can be used for safety assessment. This
product expresses a bacterial cold shock domain pro-
tein B (Bacillus subtilis CSPB), which imparts re-
duced yield loss under water-limited conditions
compared with conventional corn (Castiglioni et al.
2008). CSPB is a member of the cold shock domain-
containing (CSD-containing) protein family. Under
environmental stress, CSD-containing proteins mod-
erate stress responses in bacteria and plants, primarily
through stabilization of RNA and improved cellular
function (Cristofari and Darlix 2002; Chaikam and
Karlson 2008). Like endogenous CSD proteins found
in bacteria and plants, the CSPB protein in MON
87460 interacts with RNA and accumulates and lo-
calizes to rapidly growing tissues and in developing
reproductive organs, thereby helping to maintain cel-
lular function in those tissues during stress (Nemali
et al. 2014). Under water-limited conditions, there is a
trend toward improved ear growth rate for MON
87460 compared with the control plants, while the
common mechanisms of plant response to drought
stress are not altered in transgenic CSPB-expressing
maize plants (Castiglioni et al. 2008; Nemali et al.
2014). When plants were grown under well-watered
conditions, no appreciable differences between CSPB-
expressing lines and the control were detected (Cas-
tiglioni et al. 2008).
Based on the understanding of the CSPB mode of
action, the ERA for MON 87460 included six hy-
pothesis-driven studies that answered specific ques-
tions relevant to the nature of the trait, in addition to
the standard phenotypic and agronomic field trials in
the presence and absence of the trait (Sammons et al.
2014). The studies included assessments for persis-
tence outside of cultivation; root growth and devel-
opment; and drought, cold, heat, and salt tolerance
(Sammons et al. 2014). No additional abiotic stress
tolerances were identified and no differences in
season-long water consumption or root growth and
development were observed. These studies did not
reveal any potential for adverse environmental
impacts.
Example of hypothesis-driven testing: assessment
of potential for weediness12
In Australia, previous experience on assessment of
weediness has been used to assess transgenic crops.
Identification of characteristics that are relevant to
weediness/invasiveness has been based on practical
experience with more than 1200 major environmental
and agricultural weeds in diverse landscapes (Randall
2012). Weed scientists have produced a robust and
simple weed risk assessment protocol that can be
readily applied to any plant (Keese et al. 2014). In
addition, the large datasets available from weed risk
assessments include plants across the whole risk
spectrum and allow rigorous validation tests to be
conducted (Virtue et al. 2008; Stone and Byrne 2011).
The most advanced method for weed risk assess-
ment is based on the post-border weed risk manage-
ment protocol (Auld 2012), which was developed as a
means of prioritizing existing weeds for control. It can
be adapted to risk assessment of GM plants (Keese
et al. 2014) by comparing the weed risk of the GM
plant to that of the conventional counterpart. This
approach is used to identify significant changes based
on three factors: the risk context (i.e., the environment
where the GM crop might be present), the ability of the
GM plant to spread and persist, and the potential
negative impacts on biodiversity, non-target organ-
isms, soil nutrients, etc.
The weed risk approach specifies relevant charac-
teristics of GM plants that affect spread and persis-
tence (invasiveness) and those that potentially give
rise to negative impacts on human or animal health, or
the environment. These characteristics capture chan-
ges due to either intended or unintended effects.
Changes that have no or negligible effect on weed risk
need not be explored. The post-border weed risk
assessment approach therefore provides guidance on
the data requirements, for both intended and unin-
tended traits, that are considered relevant for the ERA
of a GM plant.
11 Section based on presentation by Elena Rice. 12 Section based on presentation by Paul Keese.
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Unintended effects on non-target organisms13
A common concern associated with the growing of
GM crops is over their potential to have adverse im-
pacts on non-target organisms. Arthropods in par-
ticular form a major part of the biodiversity in
agricultural landscapes, and many are valued because
they provide important ecosystem services, including
biological control, pollination, and decomposition, or
cultural services, including human enjoyment and
education (Sanvido et al. 2012; Garcia-Alonso and
Raybould 2014). Therefore, potential impacts that GM
plants may have on valued non-target arthropods
(NTAs) are addressed in ERA.
Both the intended change (e.g., production of a Bt
Cry [crystal] protein for target insect control) and any
unintended changes could cause unintended effects on
valued non-target organisms. Since consequences of
the intended change can be anticipated, it is possible to
construct conceptual models (pathways to harm) of
how growing of the GM plant could harm valued
NTAs and to formulate risk hypotheses that can sub-
sequently be tested (Raybould 2011). A common hy-
pothesis is that the stressor (i.e., the Cry toxin) does
not reduce the abundance and ecological functions of
NTAs under field conditions. This hypothesis is
typically tested within a tiered framework that moves
from laboratory or early-tier tests using species that
are readily available, amenable to testing, and able to
detect potential hazards, to more complex (higher-tier)
experiments that evaluate the risks under more real-
istic exposure conditions such as field studies (Romeis
et al. 2008). Laboratory studies (termed tier 1 tests) are
particularly powerful for testing the risk hypothesis; in
cases where no adverse effects are detected under
these highly controlled laboratory and worst-case ex-
posure conditions, a ‘‘no effect’’ conclusion can be
drawn with high confidence (Raybould et al. 2007;
Romeis et al. 2011).
In the case of unintended, plant-transformation-re-
lated effects, the assessment typically follows a
weight-of-evidence approach taking into account in-
formation from the molecular characterization of the
particular GM event and from comparisons of com-
position and agronomic and phenotypic characteristics
of the GM plant with its conventional counterpart
(Garcia-Alonso and Raybould 2014). If differences
are detected, their likely biological relevance will be
assessed by considering the range of values known for
the conventional crop varieties that have a history of
safe use. The aim of this assessment is to identify
potentially harmful unintended changes that, if found,
would trigger a more detailed assessment (Romeis
et al. 2008). This approach is considered sufficiently
conservative given the fact that more than 99 % of all
transformation events are eliminated during prior
agronomic and phenotypic analyses (e.g., Phillips
McDougall 2011).
It is sometimes argued that risk assessments should
include experiments to study the impact of unintended,
transformation-related effects on non-target organ-
isms. For example, the EFSA requests non-target
studies using GM plant material as a test substance to
‘‘… give indications on possible interactions between
plant compounds and reflect realistic exposure con-
ditions through bioavailability’’ (EFSA 2010). The
justification for these additional data is that the com-
positional analyses do not necessarily target specific
metabolites known to be involved in non-target-or-
ganism–plant relationships. This approach has many
limitations. For example, it is usually unknown which
metabolites are involved in these interactions, and
different metabolites are likely to affect different non-
target species differently. Furthermore it is more likely
to detect differences in plant tissue composition
among different plant varieties or even plant batches
than between the tissue from GM plants and their non-
transformed control (e.g., Meissle et al. 2014). Such
experiments and their results may thus add confusion
rather than certainty to the ERA. The published lit-
erature on the non-target impact of Bt maize, for ex-
ample, provides a number of examples where studies
using GM plant tissue as a test substance have resulted
in inconclusive results (Romeis et al. 2013).
As a solution, the unintended, transformation-re-
lated effects that might adversely affect NTAs should
be identified during the problem formulation phase of
the ERA taking into account the results from the
molecular, phenotypic, and agronomic characteriza-
tion and the compositional analyses. If such charac-
teristics are identified as stressors of concern,
pathways to harm can be constructed and testable risk
hypotheses can be formulated. This is a precondition
to design and execute meaningful studies that provide
data to support the ERA.13 Section based on presentation by Jo¨rg Romeis.
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Emerging technologies and application
to assessment of unintended effects
Omics technologies14
In contrast to the rationale described above suggesting
that a hypothesis-driven approach is sufficiently in-
formative for risk assessments, there are calls for the
use of global profiling technologies to survey the plant
more broadly than is currently feasible using a targeted
approach. As previously noted, unintended effects can
be found in both conventional and GM-based breeding
programs (Kok et al. 2008; Weber et al. 2012; Flint-
Garcia 2013). New plant breeding programs are
moving toward a broader range of molecular biologi-
cal breeding techniques to achieve more complex
genetic alterations within the framework of shorter
breeding programs (Lusser et al. 2011). In the future,
other strategies that aim for even more profound
changes, such as strategies based on synthetic biology,
may be applied to plant breeding.
For these reasons, it is useful to have more infor-
mative and cost-efficient analytical methods to screen
for unintended, potentially adverse, effects. Omics
technologies may meet these criteria. Omics technolo-
gies, whether transcriptomics (mRNA profiling), pro-
teomics (protein profiling) or metabolomics (metabolite
profiling), have already shown their added value in
different areas (Tanaka 2010; de Ligt et al. 2012; Rauch
et al. 2012). In plant materials, these methodologies can
be applied in a reproducible and informative way
(Fernie and Schauer 2009; Van Dijk et al. 2010, 2012;
Oms-Oliu et al. 2013). Such studies have confirmed that
differences between a single-trait transgenic plant va-
riety and its conventional counterpart will typically be
smaller than differences between comparable conven-
tional varieties for the analytes and time points examined.
New plant varieties could be screened for any aberrant
omics profile, i.e., a profile that is different from the
profiles of plant varieties considered as safe. New plant
varieties for which compositional profiles fall within the
range of profiles derived from plant varieties already
considered safe would not require further assessment.
This would not mean that a plant with an altered profile is
not safe, but in the case of a profile outside the range of
varieties considered as safe, a further detailed analysis of
the new plant variety would be required to confirm its
safety. This approach complements current approaches
for targeted compositional analyses, but the information
content of omics technologies will be much greater.
Statistical and chemometric methods are available to
rapidly screen profiles of new plant varieties with ref-
erence to profiles from plant varieties that we consider as
safe (Van Dijk et al. 2014). To effectively implement
omics technologies to improve current risk assessment
procedures, it is necessary to establish simple, common
protocols for omics analyses and related data analyses
with the aim to (1) compare the new plant inbred or
variety to an appropriate comparator (e.g., in the case of a
GM crop, a conventional counterpart) and (2) compare
the new plant inbred or variety to a larger set of geno-
types of the same species that are considered safe. This
approach will often relate to data that the plant breeder
will already have available, thus considerably reducing
the regulatory burden for plant breeders while safe-
guarding the food supply in the future.
Genome-scale metabolic networks
and metabolomics15
As suggested above, omics technologies have the po-
tential for enabling comprehensive and quantitative
assessment of metabolic changes in response to ge-
netic modification. While non-targeted metabolite
profiling can detect thousands of compounds, it is not
easy to understand the significance of the changed
metabolites in the biochemical and biological context
of the organism. To derive biochemical explanations
or hypotheses for the observed metabolite changes
from non-targeted metabolomics studies, it is impor-
tant to examine the changed metabolites in the context
of a genome-scale metabolic network of the organism.
Much progress has been made in the last few dec-
ades to represent metabolism at a genome scale
(Thiele and Palsson 2010). The advances in genome
sequencing and emerging fields such as biocuration
(biological database management) and bioinformatics
enabled the reconstruction of genome-scale metabolic
networks for model organisms (Bassel et al. 2012).
Genome-scale metabolic networks have been pre-
dicted from reference metabolic pathway databases
such as MetaCyc (Caspi et al. 2012), PlantCyc (Zhang
14 Section based on presentation by Esther Kok. 15 Section based on presentation by Seung Yon Rhee.
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et al. 2010), and KEGG (Kanehisa et al. 2012). These
genome-scale metabolic networks are now available
for several plant species such as Arabidopsis thaliana
(Mueller et al. 2003; Zhang et al. 2010), poplar
(Populus trichocarpa; Zhang et al. 2010), Chlamy-
domonas reinhardtii (May et al. 2009), medic (Med-
icago truncatula; Urbanczyk-Wochniak and Sumner
2007), grasses (Youens-Clark et al. 2011), and night-
shade plants (Bombarely et al. 2011).
The genome-scale metabolic networks can be used
to create predictive metabolic models (Sweetlove et al.
2008). Metabolic models can be used to predict
metabolic fluxes under a variety of scenarios such as
genetic perturbations (Feist and Palsson 2008). Two
types of metabolic models have been used: kinetic and
stoichiometric. Kinetic modeling uses enzyme kinet-
ics to numerically simulate and test metabolic fluxes
and can explain the mechanism of flux changes, but
the difficulty of determining in vivo enzyme kinetics
has limited this modeling to a small number of path-
ways. The other modeling approach uses the stoi-
chiometry of reactants and products in reactions to
solve for the most likely fluxes with added constraints
based on thermodynamics, directionality, and flux
capacity of reactions (Thiele and Palsson 2010). This
approach has been used to build genome-scale
metabolic models of several plant species such as
Arabidopsis (Poolman et al. 2009; de Oliveira Dal’-
Molin et al. 2010), maize (Saha et al. 2011), and C.
reinhardtii (Chang et al. 2011). Most of these models
have not been validated extensively using flux mea-
surements, though advances in metabolic flux analysis
using 13C-labeling and metabolomics approaches hold
promise (Schwender 2008; Sweetlove et al. 2008;
Allen et al. 2009).
These metabolic models have been applied in a
variety of studies ranging from metabolic engineering,
drug discovery, drug target discovery, identification of
novel gene function, evolutionary processes, network
behaviors, and interpretations of mutant phenotypes
(Feist and Palsson 2008). The most common algorithm
used in these studies has been flux balance analysis
(FBA), which attempts to balance the stoichiometry of
the metabolites within the metabolic network with a
goal (objective function) of maximal growth rate or
maximal biomass accumulation. While flux predic-
tions from FBA match experimental data reasonably
well (Burgard and Maranas 2003), its assumptions
may not always hold true, especially for GM or mutant
lines. Several algorithms that have the goal of
minimizing the change in the metabolic network upon
perturbation have been developed, and appear to per-
form better than FBA in explaining fluxes of mutants
(Segre` et al. 2002; Shlomi et al. 2005; Herrga˚rd et al.
2006). This type of modeling could point to bio-
chemical explanations for unintended or unexpected
metabolite changes, which could help devise hy-
pothesis-driven assessment strategies.
Using the genome-scale metabolic network of Ara-
bidopsis, Rhee and colleagues tested the effect of single
genetic perturbations of 136 genes (129 knock-out and 7
overexpression lines) by comprehensively profiling the
metabolites using 11 analytic platforms including GC–
MS, LC–MS, and ESI (Quanbeck et al. 2012). Com-
parison of the metabolite profiles across the mutants
showed that metabolic networks were robust to pertur-
bations of single metabolic genes and the genetic per-
turbations changed the network more locally than
globally (Kim and Rhee, unpublished results). This study
revealed relationships between characteristics of the
perturbed genes and metabolic changes. More analyses
of this type would help in identifying the relationships
between changed metabolites and their potential impact
on the metabolic system and biology of the organism,
which in turn would inform if altered composition could
have toxic or other harmful effects for food and feed
safety in any given crop.
Conclusions
The meeting summarized here was intended to present
and discuss a broad range of viewpoints, rather than to
arrive at a consensus on particular points. Neverthe-
less, several themes recurred in a number of presen-
tations. For example, there seemed to be little
disagreement with the observation that no system for
genetic modification, including conventional methods
of plant breeding, is without unintended effects. It was
also commonly observed that ‘‘unintended’’ is not
synonymous with ‘‘harmful’’. The testing methods
used to identify unintended effects from transgene
introduction are based on analyzing the agronomic
performance of the crop and composition of the har-
vested parts (e.g., grain, fruit, or forage). This testing,
in combination with hypothesis-based testing of the
effects and potential safety issues associated with
transgene expression minimizes the likelihood of
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unsafe unintended effects associated with the GM crop
products that are taken to commercialization.
The types of changes, such as genomic disruption
caused by (trans)gene insertion, that were once seen as
capable of leading to the production of unintended ef-
fects (e.g., in the form of novel toxins [Kessler et al.
1992]) turn out to be routine occurrences during all types
of plant breeding and are ubiquitous in crop plants. De-
spite the ongoing presence of these changes during plant
breeding and selection, there is not a single documented
example whereby these changes have led to the pro-
duction of previously unknown toxins. All reported cases
of crop toxicity have been associated with the inadver-
tent elevation of known toxins, such that testing for their
presence has become a part of the breeding process in
some crops to prevent inadvertent increases in toxin
levels (Steiner et al. 2013).
Emerging tools and resources such as genome-scale
metabolic networks, quantitative network modeling, and
metabolomics may help assess the effects of genetic
modification on metabolism and may facilitate rational
assessment of potential unintended effects of genetic
modification on metabolism. The uses of networks and
other omics-based technologies are still under assess-
ment and are viewed as possible means of identifying
potential unintended effects not tested by targeted ap-
proaches. As discussed during the meeting, there is not
yet agreement as to whether the analytical and statistical
methods currently available are sufficient to determine
whether the profile of a new variety is meaningfully
different (either globally or in the behavior of individual
data points) from those of existing varieties.
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